Key result
Trans-iliac TAVR shows feasibility with ~92% 30-day survival and sustained three-year outcomes.
Why the study?
Many vascular accesses for TAVR have been described, including the common iliac artery, but the feasibility and safety of the trans-iliac approach require evaluation.
Is trans-iliac aortic valve replacement feasible and safe in high- to intermediate-risk patients with severe aortic stenosis?
Observational (n=12)
No
Is trans-iliac aortic valve replacement feasible and safe in high- to intermediate-risk patients with severe aortic stenosis?
The trans-iliac approach for TAVR appears feasible and safe, offering a viable alternative to femoral and trans-apical routes for patients with severe aortic stenosis.
Answers are grounded in this paper and cite their sources.
May support trans-iliac TAVR as alternative access; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: Transcatheter aortic valve replacement (TAVR) is nowadays generally accepted as the treatment of choice for high- to intermediate-risk patients with severe aortic stenosis not suitable for the standard surgical replacement. Many vascular accesses have been described for the valve delivery, comprising the common iliac artery as the arterial site of access. METHODS: From September 2008 to June 2014, 440 patients underwent TAVR at our institution. We report a series of 12 patients that have undergone TAVR via a trans-iliac (TI) retroperitoneal surgical approach and also discuss its feasibility, security, and medium-term follow-up. RESULTS: The 30-day survival rate was 92%. Only 1 local vascular access major complication occurred requiring an iliac-femoral bypass grafting with a vascular graft. Two patients experienced transient neurological ischemic attack. At 3-year follow-up, all the 11 patients were alive and well and the echocardiographic evaluation revealed good function of the prosthesis. CONCLUSIONS: The TI route seems to be feasible with a low profile of local complications. It may be a reasonable access alternative to the femoral artery and to the trans-apical approach. A broader, prospective study is advisable to gain general consensus on this approach.
No takes yet. Share an insight, caveat, or question.
Gennari et al. (2019) conducted an observational in Severe aortic stenosis (n=12). Trans-iliac retroperitoneal surgical approach for TAVR was evaluated on 30-day survival rate. Trans-iliac aortic valve replacement was feasible, with a 92% 30-day survival rate and all 11 surviving patients remaining alive and well at 3-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: